Korro Bio, Inc. logo

Korro Bio, Inc.

1703647

Korro Bio is a biotechnology company focused on developing RNA therapies. They utilize their proprietary OPERA® platform to edit RNA and develop genetic medicines. Their mission is to treat debilitating and life-threatening diseases by correcting genetic mutations.

86
Erittäin Luotettava
Trust Score

Official Registry

Virallinen Nimi
Korro Bio, Inc.
Y-tunnus
1703647
Company Status
Active

AI Quality Analysis

Industry
Biotechnology
SSL/HTTPS
Secure
Ammattimainen sähköposti
Kyllä
Yhteystiedot sähköposti
informationinvestorsir@korrobio.com

🌟 Vastaavat luotettavat yritykset

Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc. logo
71/100 · Luotettava

Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with their ProCellEx® plant cell-based expression system. They focus on treating rare diseases and have already launched two enzyme replacement therapies. The company is known for its innovative ProCellEx® technology.

USA
Näytä profiili

Immunocore Holdings plc

Immunocore Holdings plc logo
75/100 · Luotettava

Immunocore Holdings plc pioneers TCR therapy, aiming to improve outcomes for patients with cancer, infectious, and autoimmune diseases. They develop transformative immunomodulating medicines using their ImmTAX technology. This technology activates the immune system to recognize and destroy diseased cells.

USA
Näytä profiili

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. logo
71/100 · Luotettava

PacBio provides advanced DNA sequencing solutions, including Revio, Vega, and Onso systems. They are known for their HiFi long-read and SBB short-read technologies, used in research across human, plant, and microbial genomics. The company is positioned as a leading provider for precise and comprehensive genetic analysis.

USA
Näytä profiili